Discover the latest articles and industry news about health system specialty pharmacy, Excelera and the Excelera Network.
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19
Vinay Sawant, RPh, MPH, MBA; Ayse Hursid, PharmD; Osama Abdelghany, PharmD, MHA, BCOP; and Terri Sue Bukowski, PharmD, CSP The coronavirus disease 2019 (COVID-19) pandemic has resulted in rewriting the proverbial “playbook” for all organizations. Information has been in a constant state of fluidity since the pandemic began and employees had to depend on myriad…
New Program Develops and Implements Customized Payer Access Blueprint for Health System Specialty Pharmacies
By Meredith Holt, National Vice President of Sales Key Concepts Payer access is a significant barrier to delivering care to complex patients. Gaining and retaining access to payers is challenging for health system specialty pharmacies. The Excelera Payer Access Program provides expert education and analysis, identifies high-value targets and the ideal payer mix, cultivates contractual…
Skin Cancer Awareness Month and the Importance of Skin Care
Pharmacy Times® spoke with Jennifer Craig, PharmD, CSP, about Skin Cancer Awareness Month and the importance of skin care. Craig said that the health care industry is constantly evolving and improving patient care services, but more specifically in specialty pharmacy, the collaboration of care has been key. Further, with the coronavirus disease 2019 pandemic, Craig…
The Importance of Payer Access to Health System Specialty Pharmacies
By Meredith Holt, National Vice President of Sales Key Concepts Health system specialty pharmacies typically experience high lost script rates, meaning they are contractually unable to dispense specialty medications to patients who are referred to them and must transfer the prescriptions to another specialty pharmacy. Challenges to accessing managed care contracts include specialty drug lock-outs,…
New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia
Erin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Growth of Health System-Based Specialty Pharmacy to Continue in 2020, Reducing Cost of Care
By Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp
Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.
Hormone receptor-positive (HR-positive) breast cancer is the most common subtype of invasive breast cancer. Treatment has been focused on targeting the estrogen receptor pathway, and endocrine therapy (ET) has remained the mainstay treatment for these patients.
Improving care for cystic fibrosis patients with pharmacy program
For people living with cystic fibrosis, St. Luke’s is making it easier to keep up, by putting a pharmacy directly in the clinic. A new grant from the Cystic Fibrosis Foundation goes towards implementing a pharmacy program for the center in Boise.
Children are a big deal at St. Luke’s. The $42 million, 100,000-square foot Idaho Elks Children’s Pavilion, which opened this summer in Boise, makes that very clear. But caring for children goes beyond the Children’s Pavilion and extends across the St. Luke’s Health System.